DNA damage can occur naturally or
through environmental factors,
leading to mutations in DNA replication and genomic instability in
cells. Normally, natural d-nucleotides were selected by DNA
polymerases. The template l-thymidine (l-T) has
been shown to be bypassed by several types of DNA polymerases. However,
DNA replication fidelity of nucleotide incorporation opposite l-thymidine in vivo remains unknown. Here, we constructed plasmids
containing a restriction enzyme (PstI) recognition
site in which the l-T lesion was site-specifically located
within the PstI recognition sequence (CTGCAG). Further,
we assessed the efficiencies of nucleotide incorporation opposite
the l-T site and l-T lesion bypass replication in
vitro and in vivo. We found that recombinants containing the l-T lesion site inhibited DNA replication. In addition, A was incorporated
opposite the l-T lesion by routine PCR assay, whereas preference
for nucleotide incorporation opposite the l-T site was A
(13%), T (22%), C (46%), and G (19%), and no nucleotide insertion
and deletions were detected in E. coli cells. In
particular, a novel restriction enzyme-mediated method for detection
of the mutagenic properties of DNA lesion was established, which allows
us to readily detect restriction–digestion of the l-T-bearing plasmids. The study provided significant insight into
how mirror-image nucleosides perturb the fidelity of DNA replication
in vivo and whether they elicit mutagenic effects, which may help
to understand both how DNA damage interferes with the flow of genetic
information during DNA replication and development of diseases caused
by gene mutation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.